Adhera Therapeutics, Inc. ATRX OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score

17/100

0/4 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Adhera Therapeutics, Inc. (ATRX) .

本页证实的标准:

VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。

SharesGrow 综合评分： 16/100 其中 0/7 项标准通过。

SharesGrow 7-Criteria Score

17/100

SG Score

View full scorecard →

—

价值

N/A

No coverage

—

未來

N/A

No coverage

✗

过去

0/100

→ Income

✗

健康

0/100

Debt-to-Equity & liquidity

→ Health

✗

护城河

11/100

→ Income

成长

58/100

→ Income

—

收入

N/A

No coverage

估值概览 — ATRX

估值倍数

P/E (TTM)0.0

前瞻 P/EN/A

PEG 比率N/A

前瞻 PEGN/A

P/B 比率0.00

P/S 比率0.00

EV/EBITDA0.0

每股数据

EPS (TTM)$-1.18

每股账面价值$0.00

每股营收$0.00

每股自由现金流$0.00

收益率与内在价值

盈利收益率N/A

股息收益率0.00%

EPS：实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year	EPS（稀释）	营收	净利润	净利润率
2013	$-18.55	$2.12M	$-1.57M	-74.3%
2014	$-102.00	$500K	$-6.48M	-1295.4%
2015	$-28.00	$680K	$3.34M	490.7%
2016	$-3.53	$0.00	$-837K	-
2017	$-12.65	$0.00	$-6.22M	-
2018	$-32.80	$76.19K	$-16.76M	-21992.2%
2019	$-24.80	$252K	$-11.98M	-4753.2%
2020	$-9.80	$0.00	$-3.77M	-
2021	$-12.84	$0.00	$-6.35M	-
2022	$-1.18	$0.00	$-2.11M	-